<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01080937</url>
  </required_header>
  <id_info>
    <org_study_id>SFC-OFICA</org_study_id>
    <nct_id>NCT01080937</nct_id>
  </id_info>
  <brief_title>French Observatory of Acute Heart Failure</brief_title>
  <acronym>OFICA</acronym>
  <official_title>French Observatory of Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the last decade, progress has been made in the management of heart failure. However,
      the changing characteristics of patients and practices in the &quot;real world&quot; and their impact
      on the prognosis of patients admitted for acute heart failure remain poorly studied.

      2000 consecutive patients recruited in a single day in hospitals volunteered to participate
      in the cohort during a day dedicated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The total duration of recruitment is one day (date to be set soon by the Executive
      Committee): all patients hospitalized, and whatever their date of admission with the
      diagnosis of heart failure will be selected for the study.

      Information on each hospital stay will be obtained at baseline and at the end of the
      hospitalization by the hospital teams.

      A telephone follow-up will be conducted at 3 months among survivors and / or their doctor by
      CRAs dedicated to the French Society of Cardiology.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze survival 3 months after the end of initial hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Methods</measure>
    <time_frame>3 months</time_frame>
    <description>Compare methods of care based on clinical characteristics and hospital structures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patterns of admission</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze patterns of admission and discharge of patients, depending on their characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidities</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze the co-morbidities and their impact on care and survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug treatments</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze the evolution of drug treatment between the output and monitoring to 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resources specific diagnostic</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze the use of resources specific diagnostic: measurement of BNP or NTproBNP, conducting echocardiogram, coronary angiography, Holter-ECG, Cardiac MRI, Cardiac CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapeutic resources</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze the use of therapeutic resources based on specific clinical features: intensive care, ventilation, inotropes, ultrafiltration, introduction of beta-blockers, stimulation, implantable cardioverter defibrillator, circulatory support, graft</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>During of stay</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze the duration of stay according to clinical characteristics.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1818</enrollment>
  <condition>Acute Heart Failure</condition>
  <arm_group>
    <arm_group_label>Patient with acute heart failure</arm_group_label>
    <description>Hospitalized patient, whatever the mode of initial admission with acute heart failure</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patient, whatever the mode of initial admission with acute heart failure (de
        novo heart failure or decompensation of chronic heart failure)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female age (e) over 18 years

          2. Inpatient, whatever the mode of initial admission with acute heart failure (de novo
             heart failure or decompensation of chronic heart failure) regardless of severity,
             corresponding to one of the following clinical situations (clinical criteria in
             Appendix 1):

               -  Pulmonary edema, hypertensive or not

               -  congestive heart failure (pulmonary congestion and peripheral edema)

               -  cardiogenic shock

               -  Insufficient high output cardiac

          3. Patients who agreed to participate in the study

          4. Isolated right heart failure

        Exclusion Criteria:

          1. expressed refusal to participate in the study

          2. Hospitalization scheduled for review

          3. Background surgery (immediate postoperative period)

          4. Diagnosis of acute heart failure reversed in favor of an alternative diagnosis before
             discharge from hospital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damien DL LOGEART</last_name>
    <role>Principal Investigator</role>
    <affiliation>French Cardiology Society</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lariboisiere Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Logeart D, Isnard R, Resche-Rigon M, Seronde MF, de Groote P, Jondeau G, Galinier M, Mulak G, Donal E, Delahaye F, Juilliere Y, Damy T, Jourdain P, Bauer F, Eicher JC, Neuder Y, Trochu JN; Heart Failure of the French Society of Cardiology. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail. 2013 Apr;15(4):465-76. doi: 10.1093/eurjhf/hfs189. Epub 2012 Nov 27.</citation>
    <PMID>23186936</PMID>
  </results_reference>
  <results_reference>
    <citation>Logeart D. [The OFICA study of acute heart failure]. Soins. 2013 Apr;(774):35. French.</citation>
    <PMID>23697057</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2010</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>French Cardiology Society</investigator_affiliation>
    <investigator_full_name>Logeart Damien</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>acute heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

